Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2019 filings

All 63 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2019, sourced directly from the official regulator.

63 Filings
2019 Period
2019 filings (63)
Filing Released Lang
Change of Director's Interest Notice (RM, MD, GM, GP, WG) 10 pages 346.7KB
Director's Dealing
2019-12-23 English
Change in substantial holding 3 pages 207.2KB
Major Shareholding Notification
2019-12-22 English
Appendix 3B 13 pages 344.5KB
Share Issue/Capital Change
2019-12-22 English
Change of Director's Interest Notice - RM 2 pages 226.6KB
Director's Dealing
2019-12-19 English
Change of Director's Interest Notice - WG 2 pages 198.7KB
Director's Dealing
2019-12-19 English
Change of Director's Interest Notice (RM) 2 pages 227.7KB
Director's Dealing
2019-12-18 English
Appendix 3B 13 pages 341.5KB
Capital/Financing Update
2019-12-18 English
Appendix 3B 13 pages 341.2KB
Capital/Financing Update
2019-12-17 English
Change of Director's Interest Notice (GM) 2 pages 229.7KB
Director's Dealing
2019-12-17 English
Change of Director's Interest Notice (MD) 2 pages 228.5KB
Director's Dealing
2019-12-17 English
Antisense Therapeutics - Underwriting of Listed Options 2 pages 129.9KB
Capital/Financing Update
2019-12-16 English
Positive results reaffirm plans to advance ATL1102 to P2b 6 pages 342.4KB
Capital/Financing Update
2019-12-16 English
Reinstatement to Official Quotation 1 page 218.3KB
Regulatory Filings
2019-12-16 English
Suspension from Official Quotation 2 pages 447.9KB
Regulatory Filings
2019-12-15 English
Appendix 3B 13 pages 340.5KB
Capital/Financing Update
2019-12-15 English
Change of Director's Interest Notice - RM 2 pages 223.1KB
Director's Dealing
2019-12-15 English
Trading Halt 2 pages 446.6KB
Regulatory Filings
2019-12-11 English
Clarification of the Trading Halt 1 page 73.6KB
Regulatory Filings
2019-12-11 English
AGM Presentation 2019 26 pages 2.4MB
AGM Information
2019-12-10 English
Results of Meeting 2 pages 264.5KB
Declaration of Voting Results & Voting Rights Announcements
2019-12-10 English
Appendix 3B 13 pages 264.4KB
Capital/Financing Update
2019-12-03 English
Change of Director's Interest Notice - Robert Moses 2 pages 277.6KB
Director's Dealing
2019-12-03 English
Appendix 3B 13 pages 311.3KB
Capital/Financing Update
2019-11-24 English
Dosing completed in ATL1102 Phase II DMD trial 2 pages 151.3KB
Capital/Financing Update
2019-11-19 English
Additional ATL1102 trial data presented at DMD UK conference 19 pages 1.9MB
Capital/Financing Update
2019-11-17 English
Expiry of Listed Options 2 pages 156.7KB
Capital/Financing Update
2019-11-14 English
Antisense Therapeutics Listed Option ANPOB Exercise 1
Capital/Financing Update
2019-11-12 English
Appendix 3B 13 pages 263.6KB
Capital/Financing Update
2019-11-11 English
Notice of Annual General Meeting/Proxy Form 92 pages 10.2MB
AGM Information
2019-11-10 English
Annual Report 64 pages 8.9MB
Annual Report
2019-10-30 English
Appendix 4G 13 pages 212.4KB
Governance Information
2019-10-30 English
Appendix 3B 13 pages 263.8KB
Capital/Financing Update
2019-10-28 English
Appendix 4C - quarterly 5 pages 298.3KB
Interim / Quarterly Report
2019-10-24 English
Neuromuscular Drug Development Summit Poster Presentation 3 pages 523.3KB
Regulatory Filings
2019-10-24 English
Techknow Conference Presentation 17 pages 2.5MB
Investor Presentation
2019-10-21 English
ANP to present at Neuromuscular Drug Development Summit USA 4 pages 190.0KB
Investor Presentation
2019-10-16 English
Change in substantial holding 4 pages 258.0KB
Major Shareholding Notification
2019-10-10 English
Response to ASX Price Query 5 pages 495.4KB
Regulatory Filings
2019-10-06 English
Appendix 3B 13 pages 316.7KB
Capital/Financing Update
2019-10-03 English
Positive preliminary results from ATL1102 DMD Phase II trial 4 pages 449.6KB
Regulatory Filings
2019-09-17 English
Trading Halt 2 pages 445.2KB
Regulatory Filings
2019-09-16 English
ATL1102 for DMD European regulatory interactions 2 pages 166.8KB
Regulatory Filings
2019-09-01 English
Appendix 4E and Full Year Statutory Accounts 74 pages 936.1KB
Annual Report
2019-08-29 English
Acromegaly Early Access Program Status Update 2 pages 155.9KB
Regulatory Filings
2019-08-25 English
Change in substantial holding 5 pages 267.2KB
Regulatory Filings
2019-07-30 English
Phase II DMD clinical trial on track for dosing completion 2 pages 107.9KB
Regulatory Filings
2019-07-23 English
Appendix 4C - quarterly 5 pages 209.1KB
Interim / Quarterly Report
2019-07-17 English
Conference Presentation 20 pages 2.9MB
Investor Presentation
2019-06-24 English
Updated Investor Presentation 20 pages 2.7MB
Investor Presentation
2019-05-28 English
Phase II clinical trial in DMD Fully Enrolled 2 pages 136.8KB
Regulatory Filings
2019-05-23 English
Appendix 4C - quarterly 5 pages 231.5KB
Interim / Quarterly Report
2019-04-25 English
Employee Share Ownership Plan (ESOP) 1 page 63.2KB
Capital/Financing Update
2019-04-25 English
Phase II clinical trial in DMD Update 3 pages 166.3KB
Regulatory Filings
2019-04-03 English
Change in substantial holding 5 pages 221.4KB
Major Shareholding Notification
2019-03-17 English
Completion of $1,600,000 Share Placement 15 pages 363.4KB
Capital/Financing Update
2019-03-14 English
Becoming a substantial holder CityCastle Pty Ltd 4 pages 819.7KB
Major Shareholding Notification
2019-03-14 English
Placement to Accelerate Development of ATL1102 in DMD 2 pages 110.7KB
Capital/Financing Update
2019-03-12 English
Pause in trading 1 page 112.2KB
Regulatory Filings
2019-03-10 English
Trading Halt 2 pages 647.1KB
Regulatory Filings
2019-03-10 English
Half Yearly Report and Accounts 25 pages 578.1KB
Interim / Quarterly Report
2019-02-26 English
Appendix 4C - quarterly 5 pages 210.1KB
Interim / Quarterly Report
2019-01-29 English
Updated Company Presentation 15 pages 3.9MB
Investor Presentation
2019-01-22 English
Phase II clinical trial in DMD Update 2 pages 138.3KB
Regulatory Filings
2019-01-17 English